➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
McKinsey
McKesson
Harvard Business School
Medtronic

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MT-8554

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Clinical Trials for MT-8554

Trial ID Title Status Sponsor Phase Summary
NCT02429102 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects Completed Mitsubishi Tanabe Pharma Corporation Phase 1 The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-8554 in healthy Caucasian subjects.
NCT02536209 A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects Completed Mitsubishi Tanabe Pharma Corporation Phase 1 The purpose of this study is to investigate the pharmacodynamic effect of single doses of MT-8554 in healthy subjects.
NCT02675309 A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects Completed Mitsubishi Tanabe Pharma Corporation Phase 1 The purpose of this study is to investigate the effect of MT-8554 on the pharmacokinetics of simvastatin and rosuvastatin in healthy subjects.
NCT02803268 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms Recruiting Mitsubishi Tanabe Pharma Corporation Phase 1 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms
NCT03172598 Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy Not yet recruiting Mitsubishi Tanabe Pharma Corporation Phase 2 A Study to Investigate the Safety, Tolerability and Efficacy of Multiple Doses of MT-8554 in Subjects with Painful Diabetic Peripheral Neuropathy
NCT03291067 MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women Recruiting Mitsubishi Tanabe Pharma Development America, Inc. Phase 2 The purpose of this study is to assess the efficacy and safety of MT-8554 for treatment of vasomotor symptoms (VMS) associated with menopause.
NCT03471130 Definitive QT Study With MT-8554 Recruiting Mitsubishi Tanabe Pharma Development America, Inc. Phase 1 This is a study to definitively assess the effects of MT 8554, adjusted for placebo, on the change of the QT interval corrected for heart rate (HR) using the Fridericia formula (QTcF) from Baseline in healthy adult subjects
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for MT-8554

Condition Name

Condition Name for
Intervention Trials
Healthy 3
Vasomotor Symptoms (VMS) 1
Vasomotor Symptoms 1
Painful Diabetic Peripheral Neuropathy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for
Intervention Trials
Pain 1
Diabetic Neuropathies 1
Hot Flashes 1
Peripheral Nervous System Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for MT-8554

Trials by Country

Trials by Country for
Location Trials
United States 26
United Kingdom 4
Poland 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for
Location Trials
Texas 2
Florida 2
Arizona 2
Missouri 2
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for MT-8554

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 2 3
Phase 1 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Recruiting 4
Completed 3
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for MT-8554

Sponsor Name

Sponsor Name for
Sponsor Trials
Mitsubishi Tanabe Pharma Corporation 5
Mitsubishi Tanabe Pharma Development America, Inc. 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
AstraZeneca
Baxter
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.